PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 2026BMJ Open0 citationsOpen Access

Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) used in ambulatory palliative care for adult patients with cancer in low-income and middle-income countries: a systematic review protocol

View Full Paper
MMMebin MathewManipal Academy of Higher EducationAGArun GhoshalManipal Academy of Higher EducationJKJohnblack K KabukyeStockholm University

Key Points

  • The review seeks to identify and evaluate patient-reported outcome and experience measures in ambulatory palliative care for cancer patients in LMICs.
  • Developed according to PRISMA guidelines.
  • Conducting a systematic search across seven databases until December 2025.
  • Two independent reviewers will screen titles and abstracts.
  • Data extraction will focus on study characteristics and psychometric properties of instruments.
  • Narrative synthesis aligning instruments with quality palliative care guidelines.
  • Current use and characteristics of PROMs and PREMs in LMICs are poorly understood.
  • The review aims to highlight gaps in measurement and inform future development of instruments.
  • A meta-analysis will be performed if data homogeneity allows.

Abstract

Introduction The global burden of cancer is increasingly concentrated in low-income and middle-income countries (LMICs), where health systems face significant challenges such as late-stage diagnosis, limited resources and restricted access to specialised care. Palliative care plays a vital role in improving symptom control and quality of life for patients with cancer, particularly as care delivery shifts toward ambulatory and community-based settings. In this context, patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are crucial for capturing patients’ perspectives on the quality of care. However, the use and characteristics of these instruments in ambulatory palliative care settings within LMICs remain poorly understood. This systematic review aims to identify and map PROMs and PREMs used among adult patients with cancer receiving ambulatory palliative care in LMICs, and to examine their content, psychometric properties and alignment with key domains of quality palliative care. Methods and analysis This systematic review protocol was developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA) guidelines. The search will be conducted across seven databases from the database inception to December 2025. Two independent reviewers will screen titles, abstracts and full-text articles using Rayyan software to identify studies involving adults (≥18 years) with cancer in ambulatory palliative care settings. Data extraction will capture study characteristics, instrument content and psychometric properties. The final review will be reported in accordance with the PRISMA-COSMIN for Outcome Measurement Instruments. A narrative synthesis will be conducted, mapping the identified instruments against the eight domains of the National Consensus Project Clinical Practice Guidelines for Quality Palliative Care to identify measurement gaps and inform future instrument development. A meta-analysis will be conducted if sufficient homogeneity exists. Ethics and dissemination This review will include only published data; therefore, no approval is required. The findings of this review will be presented at conferences and published in an open-access peer-reviewed journal. PROSPERO registration number CRD420251273579.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mathew et al. (2026) studied this question.

synapsesocial.com/papers/69e3203440886becb653f54ahttps://doi.org/10.1136/bmjopen-2026-117726
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement2015 · 27,011 citations
  2. 2Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2024 · 25,401 citations
  3. 3Rayyan—a web and mobile app for systematic reviews2016 · 26,167 citations
  4. 4Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 20242024 · 115 citations
  5. 5The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021 · 103,986 citations